Evidence map›Paper›PMID 32369504›Full record

ArticlePloS one2020

Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India.

Chinmay Laxmeshwar, Shrikala Acharya, Mrinalini Das, Padmaja Keskar, Amar Pazare, Nayana Ingole, Preeti Mehta, Pooja Gori, Homa Mansoor, Stobdan Kalon and 4 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chinmay LaxmeshwarMédecins Sans Frontières, Mumbai, India.ORCID 0000-0003-1561-3857
Shrikala AcharyaMumbai Districts AIDS Control Society, Mumbai, India.
Mrinalini DasMédecins Sans Frontières, Mumbai, India.ORCID 0000-0002-1354-4299
Padmaja KeskarMumbai Districts AIDS Control Society, Mumbai, India.
Amar PazareKEM Hospital, Mumbai, India.
Nayana IngoleKEM Hospital, Mumbai, India.
Preeti MehtaKEM Hospital, Mumbai, India.
Pooja GoriKEM Hospital, Mumbai, India.
Homa MansoorMédecins Sans Frontières, Mumbai, India.
Stobdan KalonMédecins Sans Frontières, Mumbai, India.
Pramila SinghMédecins Sans Frontières, Mumbai, India.
Taanya MathurMédecins Sans Frontières, Mumbai, India.
Gabriella FerlazzoSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.
Petros IsaakidisSouthern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRoutine viral-load (VL) measurements along with enhanced adherence counselling (EAC) are recommended to achieve virological suppression among people living with HIV/AIDS (PLHA) on anti-retroviral therapy (ART). The Mumbai Districts AIDS Control Society along with Médecins Sans Frontières has provided routine VL measurements and EAC to PLHA on ART at King Edward Memorial (KEM) hospital, Mumbai since October-2016. This study aims to describe the initial VL results and impact of EAC on viral suppression and factors associated with initial viral non-suppression among patients with an initial detectable VL, in a cohort of patients tested between October-2016 and September-2018.

methodsThis is a descriptive study of PLHA on ART who received VL testing and EAC during October-2016 to September-2018. Log-binomial regression was used to identify factors associated with a high VL.

resultsAmong 3849 PLHA who underwent VL testing, 1603(42%) were female and median age was 42 years (IQR:35-48). Majority were referred for routine testing (3432(89%)) and clinical/immunological failure (233(6%)). Overall, 3402(88%) PLHA had suppressed VL at initial testing. Among 3432 tested for routine monitoring, 3141(92%) had VL suppressed. Of 291 with VL>1000c/ml, 253(87%) received EAC and after repeat VL, 70(28%) had VL<1000c/ml. Among 233 referred for clinical/immunological failure, 122(52%) had VL>1000c/ml and 109 have been switched to second-line ART. CD4 count<500 (aOR-5.0[95%CI 3.8-6.5]), on ART for<5 years (aOR-1.5[1.1-2.0]) and age<15 years (aOR-5.2[3.0-8.9]) were associated with an initial VL>1000c/ml. Factors associated with follow-up VL suppression included EAC (p<0.05) and being on second-line ART (p<0.05).

conclusionResults from a routine VL program in public sector in India were encouraging and in line with UNAIDS 90-90-90 targets. Routine VL monitoring along with EAC resulted in early switch to alternative optimised regimens while also preventing unnecessary switches. Along with the vital scale up of routine VL monitoring, implementation of enhanced adherence strategies for patients with detectable viral load should be ensured.

Indexed as

Medication AdherenceAdultAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansIndiaMaleMiddle AgedViral LoadAnti-HIV Agents

Identifiers

PMID32369504
PMCPMC7199933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.